A Phase Ii Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study
AuthID
P-00V-T4E
P-00V-T4E
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service